Peptide Association LLC is a for-profit company. We receive compensation from the clinical providers listed on this site. We are not an accrediting body, a licensing board, or a government-affiliated organization. See exactly how we make money.
Peptide Association LLC is a for-profit company. We receive compensation from the clinical providers listed on this site. We are not an accrediting body, a licensing board, or a government-affiliated organization. See exactly how we make money.
Articles, guides, and regulatory updates from our community.
A 2026 review in Current Pain and Headache Reports examines regenerative peptides for chronic pain and tissue repair. Learn what the evidence shows.
By Peptide Association Research Team
A 2026 clinical trial suggests Phellinus igniarius decoction may help restore immune function in colorectal cancer patients following chemotherapy. Read the findings.
By Peptide Association Research Team
A 2026 clinical review explores regenerative peptides like BPC-157, TB-4, and GHK-Cu for tissue repair and chronic pain. Here's what the evidence says.
By Peptide Association Research Team
A 2026 review examines regenerative peptides like BPC-157, TB-500, and GHK-Cu for chronic pain and tissue repair. Learn what the evidence says.
By Peptide Association Research Team
A 2026 review examines regenerative peptides for chronic pain and tissue repair. Learn what the research suggests and how to find a qualified provider.
By Peptide Association Research Team
A 2026 scoping review in the American Journal of Sports Medicine examines peptide supplement evidence for musculoskeletal recovery. Here's what the data shows.
By Peptide Association Research Team
A 2026 review examines approved and unapproved peptides for musculoskeletal injuries and athletic performance. Learn what the evidence actually shows.
By Peptide Association Research Team
A 2026 scoping review in the American Journal of Sports Medicine examines BPC-157, TB-500, MK-677, and other peptides for musculoskeletal recovery.
By Peptide Association Research Team
A 2026 study in 3 Biotech found BPC-157 chitosan hydrogel showed promising antibacterial and drug delivery properties. Learn what the research suggests.
By Peptide Association Research Team
New research explores how mitochondrial dysfunction drives postoperative cognitive decline and which targeted therapies show neuroprotective promise in preclinical studies.
By Peptide Association Research Team
A 2026 study in 3 Biotech fabricated a BPC-157 chitosan hydrogel showing promising antibacterial and biocompatible properties for future biomedical use.
By Peptide Association Research Team
New research explores a BPC-157 chitosan hydrogel with strong encapsulation, antibacterial properties, and biocompatibility. Learn what the findings suggest.
By Peptide Association Research Team
A 2026 study in 3 Biotech fabricated a BPC-157 chitosan hydrogel with promising antibacterial and drug-delivery properties. Here's what the research suggests.
By Peptide Association Research Team
A 2026 study published in 3 Biotech characterized a BPC-157 chitosan hydrogel showing promising antibacterial and biocompatible properties for biomedical use.
By Peptide Association Research Team
A 2026 study in 3 Biotech fabricated a BPC-157 chitosan hydrogel showing strong encapsulation, antibacterial activity, and biocompatibility in lab testing.
By Peptide Association Research Team
A 2026 study in 3 Biotech found that a BPC-157 chitosan hydrogel showed promising antibacterial and biocompatible properties. Learn what researchers discovered.
By Peptide Association Research Team
New research explores how antimicrobial peptide-functionalized nanoparticles activated by near-infrared light may help eradicate biofilms in diabetic wounds.
By Peptide Association Research Team
New research suggests a biomimetic hematoma scaffold may regenerate large bone defects using a fraction of the rhBMP-2 dose currently used in clinical practice.
By Peptide Association Research Team
New research explores antimicrobial peptide-functionalized nanoparticles activated by NIR light to fight biofilms in diabetic wounds. Learn what the study found.
By Peptide Association Research Team
New research explores how antimicrobial peptide-functionalized nanoparticles activated by near-infrared light may help eradicate biofilms in diabetic wounds.
By Peptide Association Research Team
New research explores NIR-activated antimicrobial peptide nanoparticles that may help eradicate biofilms in diabetic wounds without promoting antibiotic resistance.
By Peptide Association Research Team
New research explores antimicrobial peptide nanoparticles activated by near-infrared light to combat biofilm infections in diabetic wounds. Learn what the study found.
By Peptide Association Research Team
New research suggests a biomimetic hematoma scaffold may enable ultra-low-dose BMP-2 to outperform standard bone repair methods. Learn what the study found.
By Peptide Association Research Team
A 2026 clinical study suggests HMB supplementation may support immune response and intracellular protein synthesis in critically ill ICU patients. Learn what researchers found.
By Peptide Association Research Team